Ibuprofen as Adjunct in Drug-Resistant Tuberculosis Trial
In a groundbreaking development that may redefine adjunct therapies in the battle against tuberculosis (TB), a recent phase IIA open-label ...
In a groundbreaking development that may redefine adjunct therapies in the battle against tuberculosis (TB), a recent phase IIA open-label ...
Immunotherapy for tuberculosis (TB) has emerged as a promising strategy to combat one of the world's most persistent infectious diseases. ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine